ChartRow logo
PAHC
$38.80-1.37%
as of close, Oct 20, 2026
☾ AH $38.80 -1.37%
PeersMRNALLYMDTUNHJNJTMO
Share this page

PAHC financial statements

The full income statement, balance sheet, and cash-flow statement for Phibro Animal Health Corporation (PAHC), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 40.6M2024-09 40.6M2024-12 40.7M2025-03 40.7M2025-06 40.7M2025-09 40.9M2025-12 41.0M2026-03 41.0M2026-06 40.6M+0.1% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2026FY2025FY2024FY2023FY2022
Income Statementas ofJun 30 ’26as ofJun 30 ’25as ofJun 30 ’24as ofJun 30 ’23as ofJun 30 ’22
Revenue1.52B+17.1%1.30B+27.4%1.02B+4.1%978M+3.8%942M+13.1%
513M+28.1%400M+27.7%313M+5.0%298M+4.5%285M+5.2%
Cost of revenue1.01B+12.2%896M+27.2%705M+3.7%680M+3.5%657M+16.9%
Research & development24.6M+3.5%23.7M-18.7%29.2M+19.7%24.4M+17.1%20.8M+17.3%
Selling, general & administrative318M+9.9%289M+11.4%260M+14.7%226M+9.7%206M+5.0%
Restructuring
——366K——
Amortization of intangibles6.88M-12.3%7.84M-18.8%9.66M-0.4%9.70M+8.7%8.92M+2.4%
Provision for credit losses281K-69.8%931K-39.5%1.54M+63.1%943K+269.8%255K+142.9%
Operating income194M+76.0%110M+107.2%53.3M-25.8%71.8M-9.0%79.0M+5.5%
Interest expense46.4M+24.7%37.2M+61.8%23.0M+23.2%18.7M+47.2%12.7M-7.5%
Net interest income———-15.3M-29.0%-11.9M+7.8%
Pre-tax income137M+102.0%68.0M+522.9%10.9M-79.8%54.1M-25.2%72.3M+8.8%
Income tax37.6M+90.7%19.7M+132.1%8.50M-60.4%21.5M-7.3%23.2M+91.6%
99.7M+106.6%48.3M+1897.7%2.42M-92.6%32.6M-33.7%49.2M-9.6%
Net income to common99.7M+106.6%48.3M+1897.7%2.42M-92.6%32.6M-33.7%49.2M-9.6%
$2.43+104.2%$1.19+1883.3%$0.06-92.6%$0.81-33.1%$1.21-9.7%
EPS (basic)$2.46+106.7%$1.19+1883.3%$0.06-92.6%$0.81-33.1%$1.21-9.7%
Weighted-avg shares (basic)40.5M+0.1%40.5M+0.0%40.5M+0.0%40.5M+0.0%40.5M+0.1%
Weighted-avg shares (diluted)41.0M+0.7%40.7M+0.4%40.5M+0.0%40.5M+0.0%40.5M+0.0%
Dividends per share$0.48+0.0%$0.48+0.0%$0.48+0.0%$0.48+0.0%$0.48+0.0%
Balance Sheetas ofJun 30 ’26as ofJun 30 ’25as ofJun 30 ’24as ofJun 30 ’23as ofJun 30 ’22
936M+15.4%811M+34.9%601M+2.6%586M+3.4%566M+13.5%
Cash & equivalents61.4M-9.7%68.0M-3.6%70.6M+71.1%41.3M-44.4%74.2M+47.9%
Short-term investments20.6M+128.6%9.00M-79.5%44.0M+10.0%40.0M+135.3%17.0M-60.5%
Accounts receivable239M+4.7%228M+34.5%169M+3.7%163M-1.8%167M+13.4%
Inventory535M+20.4%444M+67.1%266M-4.2%278M+7.1%259M+19.8%
Other current assets79.8M+30.5%61.2M+19.9%51.0M-19.5%63.4M+28.6%49.3M+15.9%
1.50B+10.3%1.36B+38.6%982M+1.1%971M+4.3%932M+10.7%
Property, plant & equipment369M+4.1%355M+74.5%203M+4.0%196M+18.2%165M+7.0%
Operating lease right-of-use51.6M+24.8%41.3M+9.9%37.6M+5.2%35.8M-5.1%37.7M+14.3%
Goodwill60.0M+0.7%59.6M+9.3%54.6M+2.4%53.3M+0.1%53.2M+1.0%
Intangible assets30.1M-17.6%36.5M-19.0%45.0M-18.1%55.0M-13.9%63.9M+2.5%
Deferred tax assets17.0M-33.4%25.5M+31.9%19.4M+122.4%8.71M+48.9%5.85M-40.7%
Other non-current assets106M+7.0%99.5M+27.1%78.3M-4.3%81.8M-1.3%82.9M+13.9%
316M+7.8%293M+43.8%204M+16.0%176M-7.8%191M+16.3%
Accounts payable127M-7.9%138M+61.5%85.6M+15.9%73.9M-22.7%95.6M+39.8%
Deferred revenue———370K-55.0%822K-47.3%
Short-term & current debt—16.3M-45.5%29.8M+33.6%22.3M+48.6%15.0M+60.0%
Current lease liability10.6M+15.8%9.13M+22.3%7.46M+23.2%6.05M+0.0%6.05M-8.6%
Other current liabilities29.9M-4.2%31.2M+78.1%17.5M-7.0%18.9M-0.2%18.9M+9.0%
1.12B+3.8%1.08B+48.2%726M+5.3%689M+2.9%669M+11.0%
Long-term debt—615M+118.0%282M-9.4%312M+14.1%273M-8.1%
Non-current lease liability45.4M+34.6%33.7M+12.8%29.9M+2.9%29.1M-7.7%31.5M+12.5%
Operating lease liability (total)56.0M+30.6%42.9M+14.7%37.4M+6.4%35.1M-6.5%37.6M+8.5%
Deferred tax liabilities3.97M-5.4%4.20M+529.2%667K-61.1%1.71M+70.5%1.00M+6.3%
Other non-current liabilities91.5M+15.4%79.3M+25.7%63.1M+4.6%60.3M-0.3%60.5M+8.1%
385M+34.9%286M+11.3%257M-9.2%283M+7.6%262M+10.0%
Additional paid-in capital139M+1.2%137M+0.5%136M+0.3%136M+0.0%136M+0.0%
Retained earnings353M+29.4%273M+11.8%244M-6.5%261M+5.3%248M+13.6%
Accumulated other comprehensive income-106M+14.5%-124M-0.4%-124M-8.2%-114M+5.7%-121M-5.0%
Total equity incl. non-controlling385M+34.9%286M+11.3%257M-9.2%283M+7.6%262M+10.0%
Total liabilities & equity1.50B+10.3%1.36B+38.6%982M+1.1%971M+4.3%932M+10.7%
Cash Flowas ofJun 30 ’26as ofJun 30 ’25as ofJun 30 ’24as ofJun 30 ’23as ofJun 30 ’22
69.0M-13.9%80.1M-8.5%87.6M+558.1%13.3M-57.9%31.6M-34.5%
Depreciation & amortization51.5M+13.0%45.6M+26.1%36.2M+6.4%34.0M+4.0%32.7M+2.6%
Intangible amortization6.88M-12.3%7.84M-18.8%9.66M-0.4%9.70M+8.7%8.92M+2.4%
Share-based compensation1.60M+122.7%717K+50.9%475K——
Deferred income taxes7.23M+252.0%-4.75M+60.4%-12.0M-314.2%-2.90M-260.6%-803K+63.2%
Change in receivables7.49M-86.4%55.2M+536.2%8.68M+262.7%-5.33M-122.6%23.6M+29.7%
Change in inventory86.3M+94.9%44.3M+1777.2%-2.64M-123.5%11.2M-76.1%47.0M+276.1%
Change in payables-12.5M-127.4%45.6M+279.6%12.0M+152.6%-22.8M-186.6%26.4M+729.9%
-71.5M+75.2%-289M-499.0%-48.2M+34.9%-74.0M-227.8%-22.6M-21.5%
Capital expenditure59.1M+54.3%38.3M-7.1%41.2M-20.4%51.8M+39.8%37.0M+26.3%
Free cash flow9.87M-76.4%41.8M-9.8%46.4M+220.5%-38.5M-613.3%-5.39M-128.4%
Acquisitions0.00-100.0%287M+8630.3%3.28M0.00-100.0%13.5M
Other investing activities792K+169.8%-1.13M-247.9%-326K+58.0%-776K-25.2%-620K-149.2%
-6.56M-103.2%207M+3160.5%-6.77M-125.1%27.0M+65.1%16.3M+196.2%
Long-term debt issued0.000.000.000.000.00
Long-term debt repaid0.000.000.000.000.00
Common stock issued0.000.000.000.000.00
Common stock repurchased0.000.000.000.000.00
Dividends paid19.5M+0.1%19.4M+0.0%19.4M+0.0%19.4M+0.0%19.4M+0.1%
FX effect on cash2.44M+313.4%-1.14M+65.3%-3.30M-537.7%754K+154.9%-1.37M-220.7%
Net change in cash-6.62M-157.2%-2.57M-108.8%29.3M+189.0%-33.0M-237.2%24.0M+73.3%
Interest paid42.1M+31.3%32.1M+85.9%17.3M+18.4%14.6M+30.6%11.2M+3.2%
Income taxes paid20.6M+53.9%13.4M-13.2%15.4M-24.4%20.4M+14.3%17.9M-7.9%
Valuation Ratiosas ofJun 30 ’26as ofJun 30 ’25as ofJun 30 ’24as ofJun 30 ’23as ofJun 30 ’22
Market cap1.27B+22.6%1.04B+53.0%680M+22.5%555M-28.4%775M-33.8%
P/E12.8×-40.6%21.5×-58.3%51.6×+203.4%17.0×+8.0%15.8×-26.7%
P/S0.8×+4.7%0.8×+18.0%0.7×+19.8%0.6×-31.0%0.8×-41.4%
P/B3.3×-9.1%3.6×+44.6%2.5×+28.1%2.0×-33.5%3.0×-39.8%
P/FCF129.2×+419.9%24.9×+47.6%16.8×——
Earnings yield7.8%+68.5%4.6%+139.7%1.9%-67.0%5.9%-7.4%6.3%+36.5%
FCF yield0.77%-80.8%4.0%-32.2%5.9%——
Dividend yield1.5%-18.7%1.9%-34.3%2.9%-18.3%3.5%+39.6%2.5%+51.0%
Source filing10-K10-K10-K10-K10-K

About this data

Source: PAHC’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all PAHC filings on SEC EDGAR → Not investment advice.